News
A new study published in the journal of JAC-Antimicrobial Resistance showed that the pre-exposure preventive doxycycline ...
Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.
SPRINGFIELD, Ill. (WAND) — A state Democratic bill to make it faster to receive some HIV medication passed the Illinois House ...
MISTR is sex-positive, stigma-free, and proudly gay-owned and operated. Over 68 million people in the U.S. have an STI at any ...
The U.S. Supreme Court is gearing up to hear Kennedy v. Braidwood Management Inc., a case that could effectively sever access to cost-free preventive care services — including PrEP.
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...
A recent modelling study commissioned by South Africa's National Health Department warns that the discontinuation of U.S.
A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and ...
From the column: "This is a four-alarm fire. ... Let’s take a page from the early days of HIV advocacy and remember, silence ...
3d
India Today on MSNHow Donald Trump's NIH budget cut will have ripple effect across the worldWhile the decision is framed as part of a broader effort to reduce spending by the federal government, critics warn that ...
Lenacapavir, a once-a-year injection, can treat HIV, prevent transmission and stop new infections — all with a single shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results